Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

Provided By GlobeNewswire

Last update: May 8, 2025

IND clearance and initiation of global basket trial exploring AlloNK^® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies and systemic sclerosis